Fighting Shigella by Blocking Its Disease-Causing Toxin

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Shiga toxin is an AB5 toxin produced by Shigella species, while related toxins are produced by Shiga toxin-producing Escherichia coli (STEC). Infection by Shigella can lead to bloody diarrhea followed by the often fatal hemolytic uremic syndrome (HUS). In the present paper, we aimed for a simple and effective toxin inhibitor by comparing three classes of carbohydrate-based inhibitors: glycodendrimers, glycopolymers, and oligosaccharides. We observed a clear enhancement in potency for multivalent inhibitors, with the divalent and tetravalent compounds inhibiting in the millimolar and micromolar range, respectively. However, the polymeric inhibitor based on galabiose was the most potent in the series exhibiting nanomolar inhibition. Alginate and chitosan oligosaccharides also inhibit Shiga toxin and may be used as a prophylactic drug during shigella outbreaks.

Original languageEnglish
Pages (from-to)6059-6069
Number of pages11
JournalJournal of Medicinal Chemistry
Volume64
Issue number9
Early online date28 Apr 2021
DOIs
Publication statusPublished - 13 May 2021

Bibliographical note

Funding Information:
We are grateful to the Tres Cantos Open Lab Foundation for funding this project (TC-232), as well as for the participation of GSK and making the Open Lab available.

Publisher Copyright:
© 2021 The Authors. Published by American Chemical Society.

Fingerprint

Dive into the research topics of 'Fighting Shigella by Blocking Its Disease-Causing Toxin'. Together they form a unique fingerprint.

Cite this